Statistics
Publications
2
Citations
92
H-Index
2
Active since
2016
Affiliations
J H Hong is an author at Samsung (South Korea) specializing in pharmaceutics, quality standards for biosimilars, and biosimilar regulation.
Publications per year
2016–2020
2
2
Physicochemical and biological characterization of SB2, a biosimilar of Remicade® (infliximab)
J H Hong, Yuhwa Lee, Changsoo Lee et al. · mAbs · 2016 · 79 citations · Full text
Batch-to-Batch Consistency of SB4 and SB2, Etanercept and Infliximab Biosimilars
Hans C. Ebbers, Bjørn Fehrmann, M. Ottosen et al. · BioDrugs · 2020 · 13 citations · Full text
1–2 of 2